(Q35889609)

10 August 2017

Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance (English)

1 reference

10 August 2017

neoplastic stem cells

1 reference

1 reference

6

Carlos Caldas

1 reference

10 August 2017

5

Paul D Pharoah

1 reference

10 August 2017

3

Fiona M Blows

1 reference

10 August 2017

H Raza Ali

1

1 reference

10 August 2017

Sarah-Jane Dawson

series ordinal

2

1 reference

10 August 2017

Elena Provenzano

series ordinal

4

1 reference

10 August 2017

language of work or name

1 reference

23 November 2011

1 reference

10 August 2017

Breast Cancer Research

1 reference

10 August 2017

13

1 reference

10 August 2017

6

1 reference

10 August 2017

R118

1 reference

https://scigraph.springernature.com/pub.10.1186/bcr3061

10 August 2017

0 references

cites work

Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Integrin alpha 6 regulates glioblastoma stem cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

The CD44+/CD24- phenotype is enriched in basal-like breast tumors

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Molecular definition of breast tumor heterogeneity

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Purification and unique properties of mammary epithelial stem cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Prospective identification of tumorigenic breast cancer cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Potential for selection bias with tumor tissue retrieval in molecular epidemiology studies

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Stem cells, cancer, and cancer stem cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Cluster analysis and display of genome-wide expression patterns

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Tissue microarrays for high-throughput molecular profiling of tumor specimens

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer

11 July 2018

1 reference

Genetics: How to validate a breast cancer prognostic signature.

21 January 2018

1 reference

Reporting recommendations for tumor marker prognostic studies (REMARK).

21 January 2018

1 reference

Using the outcome for imputation of missing predictor values was preferred.

21 January 2018

1 reference

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

21 January 2018

1 reference

Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

21 January 2018

1 reference

Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3326560

The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22112299

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22112299

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22112299

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/BCR3061

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference

10 August 2017

1 reference